Mechanistic insight into digoxin inactivation by Eggerthella lenta augments our understanding of its pharmacokinetics

References

• Holt R. The bacterial degradation of chloramphenicol. Lancet 1967; 1:1259 - 60; http://dx.doi.org/10.1016/S0140-6736(67)92720-1; PMID: 4165044
   PubMed Web of Science ®Google Scholar
• Gingell R, Bridges JW, Williams RT. Gut flora and the metabolism of prontosils in the rat. Biochem J 1969; 114:5P - 6P; PMID: 5810066
   PubMedGoogle Scholar
• Scheline RR. The metabolism of drugs and other organic compounds by the intestinal microflora. Acta Pharmacol Toxicol (Copenh) 1968; 26:332 - 42; http://dx.doi.org/10.1111/j.1600-0773.1968.tb00453.x; PMID: 5755481
   PubMedGoogle Scholar
• Nicholson JK, Holmes E, Wilson ID. Gut microorganisms, mammalian metabolism and personalized health care. Nat Rev Microbiol 2005; 3:431 - 8; http://dx.doi.org/10.1038/nrmicro1152; PMID: 15821725
   PubMed Web of Science ®Google Scholar
• Holmes E, Kinross J, Gibson GR, Burcelin R, Jia W, Pettersson S, Nicholson JK. Therapeutic modulation of microbiota-host metabolic interactions. Sci Transl Med 2012; 4:rv6; http://dx.doi.org/10.1126/scitranslmed.3004244; PMID: 22674556
   PubMed Web of Science ®Google Scholar
• Haiser HJ, Turnbaugh PJ. Is it time for a metagenomic basis of therapeutics?. Science 2012; 336:1253 - 5; http://dx.doi.org/10.1126/science.1224396; PMID: 22674325
   PubMed Web of Science ®Google Scholar
• Wallace BD, Redinbo MR. The human microbiome is a source of therapeutic drug targets. Curr Opin Chem Biol 2013; 17:379 - 84; http://dx.doi.org/10.1016/j.cbpa.2013.04.011; PMID: 23680493
   PubMed Web of Science ®Google Scholar
• Haiser HJ, Turnbaugh PJ. Developing a metagenomic view of xenobiotic metabolism. Pharmacol Res 2013; 69:21 - 31; http://dx.doi.org/10.1016/j.phrs.2012.07.009; PMID: 22902524
   PubMed Web of Science ®Google Scholar
• Wallace BD, Wang H, Lane KT, Scott JE, Orans J, Koo JS, Venkatesh M, Jobin C, Yeh LA, Mani S, et al. Alleviating cancer drug toxicity by inhibiting a bacterial enzyme. Science 2010; 330:831 - 5; http://dx.doi.org/10.1126/science.1191175; PMID: 21051639
   PubMed Web of Science ®Google Scholar
• LoGuidice A, Wallace BD, Bendel L, Redinbo MR, Boelsterli UA. Pharmacologic targeting of bacterial β-glucuronidase alleviates nonsteroidal anti-inflammatory drug-induced enteropathy in mice. J Pharmacol Exp Ther 2012; 341:447 - 54; http://dx.doi.org/10.1124/jpet.111.191122; PMID: 22328575
   PubMed Web of Science ®Google Scholar
• Saitta KS, Zhang C, Lee KK, Fujimoto K, Redinbo MR, Boelsterli UA. Bacterial β-glucuronidase inhibition protects mice against enteropathy induced by indomethacin, ketoprofen or diclofenac: mode of action and pharmacokinetics. Xenobiotica 2014; 44:28 - 35; http://dx.doi.org/10.3109/00498254.2013.811314; PMID: 23829165
   PubMed Web of Science ®Google Scholar
• Goodman LS, Brunton LL, Chabner B, Knollmann BC. Goodman & Gilman's the pharmacological basis of therapeutics. New York: McGraw-Hill, ed. 12, 2011.
   Google Scholar
• Jacobs WA, Hoffmann A. The relationship between the structure and the biological action of the cardiac glucosides. J Biol Chem 1927; 74:787 - 793
   Google Scholar
• Vick RL, Kahn JB Jr., Acheson GH. Effects of dihydro-ouabain, dihydrodigoxin and dihydrodigitoxin on the heart-lung preparation of the dog. J Pharmacol Exp Ther 1957; 121:330 - 9; PMID: 13481854
   PubMed Web of Science ®Google Scholar
• Herrmann I, Repke K. Transformation of cardenolides by microorganisms in the intestine. In: Schubert K, editor. Proceedings of the 2nd Symposium Über Biochemische Aspekte der Steroidforschung; 1968; Berlin, Germany. Berlin: Akademie-Verlag; 1969. p. 115–119.
   Google Scholar
• Lindenbaum J, Rund DG, Butler VP Jr., Tse-Eng D, Saha JR. Inactivation of digoxin by the gut flora: reversal by antibiotic therapy. N Engl J Med 1981; 305:789 - 94; http://dx.doi.org/10.1056/NEJM198110013051403; PMID: 7266632
   PubMed Web of Science ®Google Scholar
• Saha JR, Butler VP Jr., Neu HC, Lindenbaum J. Digoxin-inactivating bacteria: identification in human gut flora. Science 1983; 220:325 - 7; http://dx.doi.org/10.1126/science.6836275; PMID: 6836275
   PubMed Web of Science ®Google Scholar
• Haiser HJ, Gootenberg DB, Chatman K, Sirasani G, Balskus EP, Turnbaugh PJ. Predicting and manipulating cardiac drug inactivation by the human gut bacterium Eggerthella lenta. Science 2013; 341:295 - 8; http://dx.doi.org/10.1126/science.1235872; PMID: 23869020
   PubMed Web of Science ®Google Scholar
• Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 1997; 25:3389 - 402; http://dx.doi.org/10.1093/nar/25.17.3389; PMID: 9254694
   PubMed Web of Science ®Google Scholar
• Söding J, Biegert A, Lupas AN. The HHpred interactive server for protein homology detection and structure prediction. Nucleic Acids Res 2005; 33:W244-8; http://dx.doi.org/10.1093/nar/gki408; PMID: 15980461
   PubMedGoogle Scholar
• Rodrigues ML, Oliveira T, Matias PM, Martins IC, Valente FM, Pereira IA, Archer M. Crystallization and preliminary structure determination of the membrane-bound complex cytochrome c nitrite reductase from Desulfovibrio vulgaris Hildenborough. Acta Crystallogr Sect F Struct Biol Cryst Commun 2006; 62:565 - 8; http://dx.doi.org/10.1107/S1744309106016629; PMID: 16754983
   PubMed Web of Science ®Google Scholar
• Bagrov AY, Shapiro JI. Endogenous digitalis: pathophysiologic roles and therapeutic applications. Nat Clin Pract Nephrol 2008; 4:378 - 92; http://dx.doi.org/10.1038/ncpneph0848; PMID: 18542120
   PubMedGoogle Scholar
• Qazzaz HM, Jortani SA, Poole JM, Valdes R Jr.. Evidence for presence of a reduced form of digoxin-like immunoreactive factor (dihydro-DLIF) in mammalian tissues. Clin Chem 1996; 42:1092 - 9; PMID: 8674194
   PubMed Web of Science ®Google Scholar
• Mathan VI, Wiederman J, Dobkin JF, Lindenbaum J. Geographic differences in digoxin inactivation, a metabolic activity of the human anaerobic gut flora. Gut 1989; 30:971 - 7; http://dx.doi.org/10.1136/gut.30.7.971; PMID: 2759492
   PubMed Web of Science ®Google Scholar
• Morowitz MJ, Denef VJ, Costello EK, Thomas BC, Poroyko V, Relman DA, Banfield JF. Strain-resolved community genomic analysis of gut microbial colonization in a premature infant. Proc Natl Acad Sci U S A 2011; 108:1128 - 33; http://dx.doi.org/10.1073/pnas.1010992108; PMID: 21191099
   PubMed Web of Science ®Google Scholar
• Schloissnig S, Arumugam M, Sunagawa S, Mitreva M, Tap J, Zhu A, Waller A, Mende DR, Kultima JR, Martin J, et al. Genomic variation landscape of the human gut microbiome. Nature 2013; 493:45 - 50; http://dx.doi.org/10.1038/nature11711; PMID: 23222524
   PubMed Web of Science ®Google Scholar
• Chen SL, Wu M, Henderson JP, Hooton TM, Hibbing ME, Hultgren SJ, Gordon JI. Genomic diversity and fitness of E. coli strains recovered from the intestinal and urinary tracts of women with recurrent urinary tract infection. Sci Transl Med 2013; 5:84ra60; http://dx.doi.org/10.1126/scitranslmed.3005497; PMID: 23658245
   PubMedGoogle Scholar
• Campia I, Gazzano E, Pescarmona G, Ghigo D, Bosia A, Riganti C. Digoxin and ouabain increase the synthesis of cholesterol in human liver cells. Cell Mol Life Sci 2009; 66:1580 - 94; http://dx.doi.org/10.1007/s00018-009-9018-5; PMID: 19288057
   PubMed Web of Science ®Google Scholar
• Zhang H, Qian DZ, Tan YS, Lee K, Gao P, Ren YR, Rey S, Hammers H, Chang D, Pili R, et al. Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth. Proc Natl Acad Sci U S A 2008; 105:19579 - 86; http://dx.doi.org/10.1073/pnas.0809763105; PMID: 19020076
   PubMed Web of Science ®Google Scholar
• Huh JR, Leung MW, Huang P, Ryan DA, Krout MR, Malapaka RR, Chow J, Manel N, Ciofani M, Kim SV, et al. Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORγt activity. Nature 2011; 472:486 - 90; http://dx.doi.org/10.1038/nature09978; PMID: 21441909
   PubMed Web of Science ®Google Scholar
• Sperry JF, Wilkins TD. Arginine, a growth-limiting factor for Eubacterium lentum. J Bacteriol 1976; 127:780 - 4; PMID: 182668
   PubMed Web of Science ®Google Scholar
• Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R, Gordon JI. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med 2009; 1:ra14; http://dx.doi.org/10.1126/scitranslmed.3000322; PMID: 20368178
   PubMed Web of Science ®Google Scholar
• Faith JJ, McNulty NP, Rey FE, Gordon JI. Predicting a human gut microbiota’s response to diet in gnotobiotic mice. Science 2011; 333:101 - 4; http://dx.doi.org/10.1126/science.1206025; PMID: 21596954
   PubMed Web of Science ®Google Scholar
• David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, Ling AV, Devlin AS, Varma Y, Fischbach MA, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 2013; http://dx.doi.org/10.1038/nature12820; PMID: 24336217
   PubMed Web of Science ®Google Scholar
• Westman EL, Canova MJ, Radhi IJ, Koteva K, Kireeva I, Waglechner N, Wright GD. Bacterial inactivation of the anticancer drug doxorubicin. Chem Biol 2012; 19:1255 - 64; http://dx.doi.org/10.1016/j.chembiol.2012.08.011; PMID: 23102220
   PubMed Web of Science ®Google Scholar
• Maurice CF, Haiser HJ, Turnbaugh PJ. Xenobiotics shape the physiology and gene expression of the active human gut microbiome. Cell 2013; 152:39 - 50; http://dx.doi.org/10.1016/j.cell.2012.10.052; PMID: 23332745
   PubMed Web of Science ®Google Scholar
• Sousa T, Paterson R, Moore V, Carlsson A, Abrahamsson B, Basit AW. The gastrointestinal microbiota as a site for the biotransformation of drugs. Int J Pharm 2008; 363:1 - 25; http://dx.doi.org/10.1016/j.ijpharm.2008.07.009; PMID: 18682282
   PubMed Web of Science ®Google Scholar
• Dethlefsen L, Relman DA. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci U S A 2011; 108:Suppl 1 4554 - 61; http://dx.doi.org/10.1073/pnas.1000087107; PMID: 20847294
   PubMed Web of Science ®Google Scholar
• Iida N, Dzutsev A, Stewart CA, Smith L, Bouladoux N, Weingarten RA, Molina DA, Salcedo R, Back T, Cramer S, et al. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science 2013; 342:967 - 70; http://dx.doi.org/10.1126/science.1240527; PMID: 24264989
   PubMed Web of Science ®Google Scholar
• Viaud S, Saccheri F, Mignot G, Yamazaki T, Daillère R, Hannani D, Enot DP, Pfirschke C, Engblom C, Pittet MJ, et al. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science 2013; 342:971 - 6; http://dx.doi.org/10.1126/science.1240537; PMID: 24264990
   PubMed Web of Science ®Google Scholar